The in vivo and in vitro experiments above demonstrated that PM2.5 could up-regulate IL-17a expression to subsequently promote the progression of NSCLC via enhancing the proliferation and EMT processes. This evidence concerns the gene IL17A and non-small cell lung carcinoma.